Dear Illumina Stock Fans, Mark Your Calendars for September 21 Illumina stock is joining the S&P 500 on Sept. 21. Here's why that matters, what's fueling growth, and what investors should watch next. Barchart · Sep 9
DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars Illumina Inc. (NASDAQ:ILMN) stock is trading higher after the company reported better-than-expected third-quarter earnings. Benzinga · Oct 31, 2025
Illumina Settles With DOJ, Veterans To End Whistleblower Lawsuit Illumina Inc. (NASDAQ:ILMN) has agreed to pay $9.8 million to resolve allegations it knowingly sold genomic sequencing systems with cybersecurity vulnerabilities to several U.S. government agencies. Benzinga · Aug 6, 2025
Cathie Wood's Ark Invest Loads Up On Coinbase, Roku, Illumina, And Bitmine Immersion On Friday, Cathie Wood-led Ark Invest made significant trades involving a number of prominent stocks including Coinbase Global Inc. (NASDAQ:COIN), Roku Inc. (NASDAQ:ROKU), Illumina Inc. (NASDAQ:ILMN), and Bitmine Immersion Technologies Inc. (NASDAQ:BMNR). Benzinga · Aug 2, 2025
These Analysts Boost Their Forecasts On Illumina Following Upbeat Results Illumina, Inc. (NASDAQ:ILMN) reported better-than-expected earnings for the second quarter on Thursday. Benzinga · Aug 1, 2025
3 Precision Medicine Stocks That Could Transform Healthcare With the robust demand for personalized medicines and the growing adoption of digital technology, the precision medicine industry is expected to witness significant growth and expansion. Hence, it could be wise to invest in quality precision medicine stocks Bristol-Myers Squibb (BMY), Regeneron Pharmaceuticals (REGN), and Illumina (ILMN) that are transforming… StockNews.com · Feb 21, 2025
3 Genomics Stocks Unlocking the Future of Medicine The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations. Hence, investors might consider investing in genomics stocks such as Bio-Techne (TECH), Illumina (ILMN), and Exelixis (EXEL), which are unlocking the future of medicine. Read more…. StockNews.com · Feb 6, 2025
3 Genomic Stocks at the Forefront of Precision Medicine Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector continues to evolve, investing in genomic stocks like Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), and Illumina (ILMN) could be beneficial. Read on…. StockNews.com · Feb 3, 2025
3 Genomic Stocks Unlocking the Secrets of DNA Genomics is becoming the future of medicine as technological advancements continue to unlock our DNA’s vast potential. Given this backdrop, investing in fundamentally sound genomics stocks like Illumina (ILMN), BioNTech (BNTX), and Bio-Techne Corp. (TECH) could be beneficial. Read more…. StockNews.com · Jan 6, 2025
Stock Market Today: Stocks Are Mixed Ahead of the Fed Two of the three main equity indexes closed higher on the first day of the final Fed Week of 2024. Kiplinger · Dec 16, 2024
3 Genomic Research Companies Pioneering Personalized Medicine With vast potential, contribution to rare disease discovery and management, and adoption of AI, the genomic research market is thriving. Hence, fundamentally solid genomic research stocks Agilent Technologies (A), Illumina (ILMN), and 10x Genomics (TXG) could be ideal buys. Read more. StockNews.com · Nov 29, 2024
3 Healthcare Stocks Innovating with AI As healthcare rapidly advances, AI-driven technologies present compelling investment opportunities. Hence, investors might find promising potential in fundamentally solid healthcare stocks like Intuitive Surgical (ISRG), Illumina (ILMN), and Teladoc Health (TDOC). Keep reading. StockNews.com · Nov 5, 2024
3 Biotech Stocks to Watch as FDA Approvals Roll In The biotech sector is booming, fueled by rising healthcare demands, exciting advancements in technology, and increased FDA drug approvals. Thus, investing in Illumina (ILMN), Alnylam Pharmaceuticals (ALNY), and Gilead Sciences (GILD) could be a golden opportunity for those looking to ride the wave of future breakthroughs. Read on…. StockNews.com · Sep 23, 2024
3 Genomics Stocks Transforming Healthcare Genomics is on the brink of revolutionizing healthcare with breakthroughs that could redefine treatment and diagnosis. As this field rapidly evolves, investing in fundamentally sound genomics stocks like Regeneron Pharmaceuticals (REGN), Alnylam Pharmaceuticals (ALNY), and Illumina (ILMN) could be beneficial. Read more…. StockNews.com · Sep 19, 2024
StockNews.com · Aug 5, 2024 3 Biotech Stocks With Anticipated Strong Earnings Reports With highly effective drugs and treatment options, chronic disease prevalence, and adoption of technology, the biotech market is thriving. Hence, fundamentally solid biotech stocks Illumina (ILMN), Amgen (AMGN), and Entrada Therapeutics (TRDA) could be ideal with anticipated strong earnings reports. Read more.
Barchart · Jul 29, 2024 What You Need to Know Ahead of Illumina's Earnings Release Illumina is expected to release its second-quarter earnings next month, analysts expect a double-digit earnings dip.
StockNews.com · Jul 15, 2024 3 Biopharma Stocks to Buy for Long-Term Growth With the rising investment in personalized medicine research and development and growing clinical trials, the biopharma industry’s prospects appear promising. Hence, quality biotech stocks, Alnylam Pharmaceuticals (ALNY), Illumina (ILMN), and Gilead Sciences (GILD) with long-term growth might be solid buys. Read more….
StockNews.com · May 14, 2024 3 Biotech Stocks to Monitor for May Moves The biotech industry is well poised to flourish, buoyed by its strong emphasis on technology-driven advancements to address complex medical challenges and government funding. Hence, quality biotech stocks Harmony Biosciences Holdings (HRMY), Illumina (ILMN), and Compugen (CGEN) could be ideal watchlist additions for May. Read more….
StockNews.com · Apr 9, 2024 3 Biotech Stocks to Buy in 2024 The biotech industry is expected to grow rapidly due to rising demand for tailored treatments, increased R&D spending, and technological advancements. Therefore, fundamentally strong biotech stocks Harmony Biosciences Holdings (HRMY), Illumina (ILMN), and Halozyme Therapeutics (HALO) could be worth adding to your portfolio. Read on.
StockNews.com · Mar 15, 2024 3 B-Rated Biotech Stocks to Boost Your Bottom Line The biotech industry’s growth prospects look promising due to innovative drugs and therapies, government initiatives, and technological advancements. Therefore, investors could consider buying fundamentally strong biotech stocks BioMarin Pharmaceutical (BMRN), Illumina (ILMN), and Harmony Biosciences (HRMY). These stocks are B-rated (Buy) in our proprietary rating system. Read on.
StockNews.com · Mar 15, 2024 3 Popular Biotech Stocks to Capitalize on Gains The biotech industry’s rapid expansion is driven by rising healthcare sending, groundbreaking innovations, and strategic collaborations, propelling the growth of biopharma companies. Thus, it could be wise to invest in popular biotech stocks Illumina (ILMN), Shionogi (SGIOY), and Regeneron Pharmaceuticals (REGN) for substantial gains. Keep reading….
StockNews.com · Feb 29, 2024 3 Biotech Stocks to Buy for Profits Beyond 2024 The biotech industry is expected to deliver steady returns amid rising medical needs and increased research and development investment. Therefore, fundamentally strong biotech stocks Illumina (ILMN), Innoviva (INVA) and Puma Biotechnology (PBYI) might be ideal additions to your portfolio. Read on.
StockNews.com · Feb 2, 2024 3 Biotech Stocks Investors Are Watching for Future Growth A wide range of applications across several sectors, supportive government initiatives, rapid technological advancements, and shifting market dynamics position the biotechnology industry for robust long-term growth. Given the industry’s bright outlook, biotech stocks MannKind (MNKD), Illumina (ILMN), and TG Therapeutics (TGTX) could be ideal watchlist additions for potential growth. Read…
StockNews.com · Jan 25, 2024 Will These 3 Biotech Stocks Make Gains in 2024? In the swiftly progressing arena of biotechnology, technological advancements, increasing merger and acquisition maneuvers, and developing product pipelines are driving significant expansion in this sector. The sector's strong potential is further reinforced by a steady demand, ensuring its sustenance. Given this backdrop, let’s analyze whether or not biotech stocks Illumina…
Benzinga · Oct 4, 2022 Looking At Illumina's Recent Whale Trades A whale with a lot of money to spend has taken a noticeably bearish stance on Illumina. Looking at options history for Illumina (NASDAQ:ILMN) we detected 26 strange trades.